Modulation of immune response by B7 family molecules in tumor microenvironments

Immunological Investigations

Volumn 35, Issue 3-4, 2006, Pages 395-418

  Flies, Dallas B ^a   Chen, Lieping ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

B7; Co inhibitory; Co stimulatory; Microenvironment; Tumor

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; CANCER IMMUNOTHERAPY; CELL COMMUNICATION; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; STROMA CELL; TUMOR; TUMOR IMMUNITY; TUMOR REGRESSION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIGENS, CD80; HUMANS; MICE; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 33747605975     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130600755017     Document Type: Review

References (132)

1. Anichini, A., Vegetti, C., Mortarini, R. (2004). The paradox of T-cell-mediated antitumor immunity in spite of poor clinical outcome in human melanoma. Cancer Immunol. Immunother. 53(10):855-864.
2. Ara, G., Baher, A., Storm, N., Horan, T., Baikalov, C., Brisan, E., Camacho, R., Moore, A., Goldman, H., Kohno, T., Cattley, R. C., Van, G., Gaida, K., Zhang, M., Whoriskey, J. S., Fong, D., Yoshinaga, S. K. (2003). Potent activity of soluble B7RP-1-Fc in therapy of murine tumors in syngeneic hosts. Int. J. Cancer 103(4):501-507.
3. Baskar, S., Ostrand-Rosenberg, S., Nabavi, N., Nadler, L. M., Freeman, G. J., Glimcher, L. H. (1993). Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 90(12):5687-5690.
4. Beissert, S., Bluestone, J. A., Mindt, I., Voskort, M., Metze, D., Mehling, A., Luger, T. A., Schwarz, T., Grabbe, S. (1999). Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulation. J. Immunol. 163(12):6725-6731.
5. Blanco, B., Holliger, P., Alvarez-Vallina, L. (2002). Autocrine costimulation: tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7-anti-CEA diabody fusion protein. Cancer Gene Ther. 9(3):275-281.
6. Blank, C., Brown, I., Peterson, A. C., Spiotto, M., Iwai, Y., Honjo, T., Gajewski, T. F. (2004). PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells. Cancer Res. 64(3):1140-1145.
7. Bosshart, H. (2004). Levels of B7-2 in tumor cells of Hodgkin's disease. Immunol. Lett. 92(3):217-220.
8. Boxhorn, H. K., Smith, J. G., Chang, Y. J., Guerry, D., Lee, W. M., Rodeck, U., Turka, L. A., Eck, S. L. (1998). Adenoviral transduction of melanoma cells with B7-1: antitumor immunity and immunosuppressive factors. Cancer Immunol. Immunother. 46(5):283- 292.
9. Brodie, D., Collins, A. V., Iaboni, A., Fennelly, J. A., Sparks, L. M., Xu, X. N., van der Merwe, P. A., Davis, S.J. (2000). LICOS, a primordial costimulatory ligand? Curr. Biol. 10(6):333-336.
10. Brown, J. A., Dorfman, D. M., Ma, F. R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A., Freeman, G. J. (2003). Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170(3):1257-1266.
11. Brown, R., Murray, A., Pope, B., Sze, D., Gibson, J., Ho, P. J., Joshua, D. (2004). B7+ T cells in myeloma: an acquired marker of prior chronic antigen presentation. Leuk. Lymphoma 45(2):363-371.
12. Carreno, B. M., Collins, M. (2002). The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 2029-2053.
13. Carter, L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., Carreno, B. M. (2002). PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur. J. Immunol. 32(3):634-643.
14. Castriconi, R., Dondero, A., Augugliaro, R., Cantoni, C., Carnemolla, B., Sementa, A. R., Negri, F., Conte, R., Corrias, M. V., Moretta, L., Moretta, A., Bottino, C. (2004). Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis. Proc. Natl. Acad. Sci. USA 101(34):12640-12645.
15. Chamberlain, R. S., Carroll, M. W., Bronte, V., Hwu, P., Warren, S., Yang, J. C., Nishimura, M., Moss, B., Rosenberg, S. A., Restifo, N. P. (1996). Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines. Cancer Res. 56(12):2832-2836.
16. Chambers, C. A., Kuhns, M. S., Egen, J. G., Allison, J. P. (2001). CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu. Rev. Immunol. 19565-19594.
17. Chapoval, A. I., Ni, J., Lau, J. S., Wilcox, R. A., Flies, D. B., Liu, D., Dong, H., Sica, G. L., Zhu, G., Tamada, K., Chen, L. (2001). B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat. Immunol. 2(3):269-274.
18. Chen, L. (2004). Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4(5):336-347.
19. Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., Linsley, P. S. (1992). Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71(7):1093-1102.
20. Chen, Y., Li, J., Zhang, J., Zhao, T., Zou, L., Tang, Y., Zhang, X., Wu, Y. (2005). Sinomenine inhibits B7-H1 and B7-DC expression on human renal tubular epithelial cells. Int. Immunopharmacol. 5(9):1446-1457.
21. Choi, I. H., Zhu, G., Sica, G. L., Strome, S. E., Cheville, J. C., Lau, J. S., Zhu, Y., Flies, D. B., Tamada, K., Chen, L. (2003). Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J. Immunol. 171(9):4650-4654.
22. Collins, A. V., Brodie, D. W., Gilbert, R. J., Iaboni, A., Manso-Sancho, R., Walse, B., Stuart, D. I., van der Merwe, P. A., Davis, S. J. (2002). The interaction properties of costimulatory molecules revisited. Immunity 17(2):201-210.
23. Cormier, J. N., Salgaller, M. L., Prevette, T., Barracchini, K. C., Rivoltini, L., Restifo, N. P., Rosenberg, S. A., Marincola, F. M. (1997). Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A. Cancer J. Sci. Am. 3(1):37-44.
24. Coyle, A. J., Gutierrez-Ramos, J. C. (2001). The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2(3):203-209.
25. Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J.R., Zhang, L., Burow, M., Zhu, Y., Wei, S., Kryczek, I., Daniel, B., Gordon, A., Myers, L., Lackner, A., Disis, M. L., Knutson, K. L., Chen, L., Zou, W. (2004). Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10(9):942-949.
26. Diefenbach, A., Tomasello, E., Lucas, M., Jamieson, A. M., Hsia, J. K., Vivier, E., Raulet, D. H. (2002). Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3(12):1142-1149.
27. Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., Lennon, V. A., Celis, E., Chen, L. (2002). Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8(8):793-800.
28. Dong, H., Zhu, G., Tamada, K., Chen, L. (1999). B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5(12):1365-1369.
29. Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., Robinson, M. R., Raffeld, M., Duray, P., Seipp, C. A., Rogers-Freezer, L., Morton, K. E., Mavroukakis, S. A., White, D. E., Rosenberg, S. A. (2002). Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298(5594):850-854.
30. Eppihimer, M. J., Gunn, J., Freeman, G. J., Greenfield, E. A., Chernova, T., Erickson, J., Leonard, J. P. (2002). Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation 9(2):133-145.
31. Ferrone, S., Finerty, J. F., Jaffee, E. M., Nabel, G. J. (2000). How much longer will tumour cells fool the immune system? Immunol. Today 21(2):70-72.
32. Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., Horton, H. F., Fouser, L., Carter, L., Ling, V., Bowman, M. R., Carreno, B. M., Collins, M., Wood, C. R., Honjo, T. (2000). Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192(7):1027-1034.
33. Gajewski, T. F., Fallarino, F., Ashikari, A., Sherman, M. (2001). Immunization of HLA-A2+ melanoma patients with MAGE-3 or MelanA peptide-pulsed autologous peripheral blood mononuclear cells plus recombinant human interleukin 12. Clin. Cancer Res. 7(3 Suppl):895s-901s.
34. Ganss, R., Hanahan, D. (1998). Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes. Cancer Res. 58(20):4673-4681.
35. Gilfillan, S., Ho, E. L., Cella, M., Yokoyama, W. M., Colonna, M. (2002). NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol. 3(12):1150-1155.
36. Greenfield, E. A., Nguyen, K. A., Kuchroo, V. K. (1998). CD28/B7 costimulation: a review. Crit. Rev. Immunol. 18(5):389-418.
37. Greenwald, R. J., Freeman, G. J., Sharpe, A. H. (2005). The B7 family revisited. Annu. Rev. Immunol. 23515-23548.
38. Greenwald, R. J., Boussiotis, V. A., Lorsbach, R. B., Abbas, A. K., Sharpe, A. H. (2001). CTLA-4 regulates induction of anergy in vivo. Immunity 14(2):145-155.
39. Grimbacher, B., Warnatz, K., Peter, H. H. (2003). The immunological synapse for B-cell memory: the role of the ICOS and its ligand for the longevity of humoral immunity. Curr. Opin. Allergy Clin. Immunol. 3(6):409-419.
40. Hathcock, K. S., Laszlo, G., Pucillo, C., Linsley, P., Hodes, R. J. (1994). Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180(2):631-640.
41. He, X. H., Liu, Y., Xu, L. H., Zeng, Y. Y. (2004a). Cloning and identification of two novel splice variants of human PD-L2. Acta Biochim. Biophys. Sin. (Shanghai) 36(4):284-289.
42. He, Y. F., Zhang, G. M., Wang, X. H., Zhang, H., Yuan, Y., Li, D., Feng, Z. H. (2004b). Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine. J. Immunol. 173(8):4919-4928.
43. Hirano, F., Kaneko, K., Tamura, H., Dong, H., Wang, S., Ichikawa, M., Rietz, C., Flies, D. B., Lau, J. S., Zhu, G., Tamada, K., Chen, L. (2005). Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res. 65(3):1089-1096.
44. Hodi, F. S., Mihm, M. C., Soiffer, R. J., Haluska, F. G., Butler, M., Seiden, M. V., Davis, T., Henry-Spires, R., MacRae, S., Willman, A., Padera, R., Jaklitsch, M. T., Shankar, S., Chen, T. C., Korman, A., Allison, J. P., Dranoff, G. (2003). Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc. Natl. Acad. Sci. USA 100(8):4712-4717.
45. Huang, B., Zhao, J., Li, H., He, K.L., Chen, Y., Mayer, L., Unkeless, J. C., Xiong, H. (2005). Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 65(12):5009-5014.
46. Ishida, M., Iwai, Y., Tanaka, Y., Okazaki, T., Freeman, G. J., Minato, N., Honjo, T. (2002). Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol. Lett. 84(1):57-62.
47. Iwai, Y., Terawaki, S., Honjo, T. (2005). PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. Int. Immunol. 17(2):133-144.
48. Iwai, Y., Terawaki, S., Ikegawa, M., Okazaki, T., Honjo, T. (2003). PD-1 inhibits antiviral immunity at the effector phase in the liver. J. Exp. Med. 198(1):39-50.
49. Iwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T., Minato, N. (2002). Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl. Acad. Sci. USA 99(19):12293-12297.
50. Jain, A., Slansky, J. E., Matey, L. C., Allen, H. E., Pardoll, D. M., Schulick, R. D. (2003). Synergistic effect of a granulocyte-macrophage colony-stimulating factor-transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastases. Ann. Surg. Oncol. 10(7):810-820.
51. Jansson, A., Barnes, E., Klenerman, P., Harlen, M., Sorensen, P., Davis, S. J., Nilsson, P. (2005). A theoretical framework for quantitative analysis of the molecular basis of costimulation. J. Immunol. 175(3):1575-1585.
52. Kim, J., Myers, A. C., Chen, L., Pardoll, D., Truong-Tran, Q. A., Lane, A., McDyer, J., Fortuno, L., Schleimer, R. P. (2005). Constitutive and inducible expression of B7 family of ligands by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 33(3):280-289.
53. Kjaergaard, J., Peng, L., Cohen, P. A., Drazba, J. A., Weinberg, A. D., Shu, S. (2001). Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor. J. Immunol. 167(11):6669-6677.
54. Konishi, J., Yamazaki, K., Azuma, M., Kinoshita, I., Dosaka-Akita, H., Nishimura, M. (2004). B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin. Cancer Res. 10(15):5094-5100.
55. Kryczek, I., Zou, L., Rodriguez, P., Zhu G, Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., Lackner, A., Alvarez, X., Ochoa, A., Chen, L., Zou, W. (2006). B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J. Exp. Med. 203(4):871-881.
56. Lane, A. P., Saatian, B., Yu, X. Y., Spannhake, E. W. (2004). mRNA for genes associated with antigen presentation are expressed by human middle meatal epithelial cells in culture. Laryngoscope 114(10):1827-1832.
57. Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., Greenfield, E. A., Bourque, K., Boussiotis, V. A., Carter, L. L., Carreno, B. M., Malenkovich, N., Nishimura, H., Okazaki, T., Honjo, T., Sharpe, A. H., Freeman, G. J. (2001). PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2(3):261-268.
58. Leach, D. R., Krummel, M. F., Allison, J. P. (1996). Enhancement of antitumor immunity by CTLA-4 blockade. Science 271(5256):1734-1736.
59. Lenschow, D. J., Su, G. H., Zuckerman, L. A., Nabavi, N., Jellis, C. L., Gray, G. S., Miller, J., Bluestone, J. A. (1993). Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. USA 90(23):11054-11058.
60. Ling, V., Wu, P. W., Finnerty, H. F., Bean, K. M., Spaulding, V., Fouser, L. A., Leonard, J. P., Hunter, S. E., Zollner, R., Thomas, J. L., Miyashiro, J. S., Jacobs, K. A., Collins, M. (2000). Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J. Immunol. 164(4):1653-1657.
61. Liu, X., Gao, J. X., Wen, J., Yin, L., Li, O., Zuo, T., Gajewski, T. F., Fu, Y.X., Zheng, P., Liu, Y. (2003). B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J. Exp. Med. 197(12):1721-1730.
62. Liu, X., Bai, X. F., Wen, J., Gao, J. X., Liu, J., Lu, P., Wang, Y., Zheng, P., Liu, Y. (2001). B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo. J. Exp. Med. 194(9):1339-1348.
63. Lohr, J., Knoechel, B., Jiang, S., Sharpe, A. H., Abbas, A. K. (2003). The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat. Immunol. 4(7):664-669.
64. Lollini, P. L., Forni, G. (1999). Specific and nonspecific immunity in the prevention of spontaneous tumours. Immunol. Today 20(8):347-350.
65. Loser, K., Scherer, A., Krummen, M. B., Varga, G., Higuchi, T., Schwarz, T., Sharpe, A. H., Grabbe, S., Bluestone, J. A., Beissert, S. (2005). An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice. J. Immunol. 174(9):5298-5305.
66. Luo, L., Chapoval, A. I., Flies, D. B., Zhu, G., Hirano, F., Wang, S., Lau, J. S., Dong, H., Tamada, K., Flies, A. S., Liu, Y., Chen, L. (2004). B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells. J. Immunol. 173(9):5445-5450.
67. Lute, K. D., May, K. F., Lu, P., Zhang, H., Kocak, E., Mosinger, B., Wolford, C., Phillips, G., Caligiuri, M. A., Zheng, P., Liu, Y. (2005). Human CTLA-4-knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies. Blood 106(9):3127-3133.
68. Maeda, A., Yamamoto, K., Yamashita, K., Asagoe, K., Nohgawa, M., Kita, K., Iwasaki, H., Ueda, T., Takahashi, A., Sasada, M. (1998). The expression of costimulatory molecules and their relationship to the prognosis of human acute myeloid leukaemia: poor prognosis of B7-2-positive leukaemia. Br. J. Haematol. 102(5):1257-1262.
69. Magnus, T., Schreiner, B., Korn, T., Jack, C., Guo, H., Antel, J., Ifergan, I., Chen, L., Bischof, F., Bar-Or, A., Wiendl, H. (2005). Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J. Neurosci. 25(10):2537-2546.
70. Mak, T. W., Shahinian, A., Yoshinaga, S. K., Wakeham, A., Boucher, L. M., Pintilie, M., Duncan, G., Gajewska, B. U., Gronski, M., Eriksson, U., Odermatt, B., Ho, A., Bouchard, D., Whorisky, J. S., Jordana, M., Ohashi, P. S., Pawson, T., Bladt, F., Tafuri, A. (2003). Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Nat. Immunol. 4(8):765-772.
71. Mazanet, M. M., Hughes, C. C. (2002). B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J. Immunol. 169(7):3581-3588.
72. Melichar, B., Nash, M. A., Lenzi, R., Platsoucas, C. D., Freedman, R. S. (2000). Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis. Clin. Exp. Immunol. 119(1):19-27.
73. Mokyr, M. B., Kalinichenko, T., Gorelik, L., Bluestone, J. A. (1998). Realization of the therapeutic potential of CTLA-4 blockade in low-dose chemotherapy-treated tumor-bearing mice. Cancer Res. 58(23):5301-5304.
74. Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., Schadendorf, D. (1998). Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat. Med. 4(3):328-332.
75. Ogasawara, K., Yoshinaga, S. K., Lanier, L. L. (2002). Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells. J. Immunol. 169(7):3676-3685.
76. Ohigashi, Y., Sho, M., Yamada, Y., Tsurui, Y., Hamada, K., Ikeda, N., Mizuno, T., Yoriki, R., Kashizuka, H., Yane, K., Tsushima, F., Otsuki, N., Yagita, H., Azuma, M., Nakajima, Y. (2005). Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin. Cancer Res. 11(8):2947-2953.
77. Orsini, E., Guarini, A., Chiaretti, S., Mauro, F. R., Foa, R. (2003). The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response. Cancer Res. 63(15):4497-4506.
78. Pardoll, D. (2001). T cells and tumours. Nature 411(6841):1010-1012.
79. Pecher, G., Haring, A., Kaiser, L., Thiel, E. (2002). Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial. Cancer Immunol. Immunother. 51(11-12):669-673.
80. Perez, V. L., Van Parijs, L., Biuckians, A., Zheng, X. X., Strom, T. B., Abbas, A. K. (1997). Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6(4):411-417.
81. Peterson, A. C., Harlin, H., Gajewski, T. F. (2003). Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma. J. Clin. Oncol. 21(12):2342-2348.
82. Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S.L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L.R., Seipp, C. A., Freezer, L. J., Morton, K. E., Mavroukakis, S. A., Duray, P. H., Steinberg, S. M., Allison, J. P., Davis, T. A., Rosenberg, S. A. (2003). Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA 100(14):8372-8377.
83. Pope, B., Brown, R. D., Gibson, J., Yuen, E., Joshua, D. (2000). B7-2-positive myeloma: incidence, clinical characteristics, prognostic significance, and implications for tumor immunotherapy. Blood 96(4):1274-1279.
84. Prasad, D. V., Nguyen, T., Li, Z., Yang, Y., Duong, J., Wang, Y., Dong, C. (2004). Murine B7-H3 is a negative regulator of T cells. J. Immunol. 173(4):2500-2506.
85. Prasad, D. V., Richards, S., Mai, X. M., Dong, C. (2003). B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 18(6):863-873.
86. Radhakrishnan, S., Nguyen, L. T., Ciric, B., Flies, D., Van Keulen, V. P., Tamada, K., Chen, L., Rodriguez, M., Pease, L. R. (2004). Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity. Cancer Res. 64(14):4965-4972.
87. Richter, G., Burdach, S. (2004). ICOS: a new costimulatory ligand/receptor pair and its role in T-cell activion. Onkologie 27(1):91-95.
88. Rosenberg, S. A., Yang, J. C., Restifo, N. P. (2004). Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10(9):909-915.
89. Rosenberg, S. A. (2001). Progress in human tumour immunology and immunotherapy. Nature 411(6835):380-384.
90. Saatian, B., Yu, X. Y., Lane, A. P., Doyle, T., Casolaro, V., Spannhake, E. W. (2004). Expression of genes for B7-H3 and other T cell ligands by nasal epithelial cells during differentiation and activation. Am. J. Physiol. Lung Cell. Mol. Physiol. 287(1):L217-225.
91. Salceda, S., Tang, T., Kmet, M., Munteanu, A., Ghosh, M., Macina, R., Liu, W., Pilkington, G., Papkoff, J. (2005). The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp. Cell Res. 306(1):128-141.
92. Salomon, B., Bluestone, J. A. (2001). Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19225-19252.
93. Saudemont, A., Jouy, N., Hetuin, D., Quesnel, B. (2005). NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. Blood 105(6):2428-2435.
94. Saudemont, A., Quesnel, B. (2004). In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis. Blood 104(7):2124-2133.
95. Schreiner, B., Wischhusen, J., Mitsdoerffer, M., Schneider, D., Bornemann, A., Melms, A., Tolosa, E., Weller, M., Wiendl, H. (2003). Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivo. Glia 44(3):296-301.
96. Schwartz, J. C., Zhang, X., Fedorov, A. A., Nathenson, S. G., Almo, S. C. (2001). Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 410(6828):604-608.
97. Shin, T., Yoshimura, K., Shin, T., Crafton, E. B., Tsuchiya, H., Housseau, F., Koseki, H., Schulick, R. D., Chen, L., Pardoll, D. M. (2005). In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses. J. Exp. Med. 201(10):1531-1541.
98. Sica, G. L., Choi, I. H., Zhu, G., Tamada, K., Wang, S. D., Tamura, H., Chapoval, A. I., Flies, D. B., Bajorath, J., Chen, L. (2003). B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18(6):849-861.
99. Singh, S., Ross, S. R., Acena, M., Rowley, D. A., Schreiber, H. (1992). Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells. J. Exp. Med. 175(1):139-146.
100. Sinkovics, J. G., Horvath, J. C. (2000). Vaccination against human cancers (review). Int. J. Oncol. 16(1):81-96.
101. Smith, K. M., Brewer, J. M., Webb, P., Coyle, A. J., Gutierrez-Ramos, C., Garside, P. (2003). Inducible costimulatory molecule-B7-related protein 1 interactions are important for the clonal expansion and B cell helper functions of naive, Th1, and Th2 T cells. J. Immunol. 170(5):2310-2315.
102. Stamper, C. C., Zhang, Y., Tobin, J. F., Erbe, D. V., Ikemizu, S., Davis, S. J., Stahl, M. L., Seehra, J., Somers, W. S., Mosyak, L. (2001). Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 410(6828):608-611.
103. Subudhi, S. K., Zhou, P., Yerian, L. M., Chin, R. K., Lo, J.C., Anders, R. A., Sun, Y., Chen, L., Wang, Y., Alegre, M. L., Fu, Y. X. (2004). Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J. Clin. Invest. 113(5):694-700.
104. Suh, W. K., Wang, S. X., Jheon, A. H., Moreno, L., Yoshinaga, S. K., Ganss, B., Sodek, J., Grynpas, M. D., Mak, T. W. (2004). The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization. Proc. Natl. Acad. Sci. USA 101(35):12969-12973.
105. Suh, W. K., Gajewska, B. U., Okada, H., Gronski, M. A., Bertram, E. M., Dawicki, W., Duncan, G. S., Bukczynski, J., Plyte, S., Elia, A., Wakeham, A., Itie, A., Chung, S., Da Costa, J., Arya, S., Horan, T., Campbell, P., Gaida, K., Ohashi, P. S., Watts, T. H., Yoshinaga, S. K., Bray, M. R., Jordana, M., Mak, T. W. (2003). The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat. Immunol. 4(9):899-906.
106. Sun, M., Richards, S., Prasad, D. V., Mai, X. M., Rudensky, A., Dong, C. (2002). Characterization of mouse and human B7-H3 genes. J. Immunol. 168(12):6294-6297.
107. Sun, X., Vale, M., Leung, E., Kanwar, J. R., Gupta, R., Krissansen, G. W. (2003). Mouse B7-H3 induces antitumor immunity. Gene Ther. 10(20):1728-1734.
108. Swallow, M. M., Wallin, J. J., Sha, W. C. (1999). B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity 11(4):423-432.
109. Sykulev, Y., Brunmark, A., Tsomides, T. J., Kageyama, S., Jackson, M., Peterson, P. A., Eisen, H. N. (1994). High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci. USA 91(24):11487-11491.
110. Tamura, H., Dan, K., Tamada, K., Nakamura, K., Shioi, Y., Hyodo, H., Wang, S. D., Dong, H., Chen, L., Ogata, K. (2005). Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia. Clin. Cancer Res. 11(16):5708-5717.
111. Tamura, H., Dong, H., Zhu, G., Sica, G. L., Flies, D. B., Tamada, K., Chen, L. (2001). B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 97(6):1809-1816.
112. Taylor, P. A., Lees, C. J., Fournier, S., Allison, J. P., Sharpe, A. H., Blazar, B. R. (2004). B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections]. J. Immunol. 172(1):34-39.
113. Thompson, R. H., Gillett, M. D., Cheville, J. C., Lohse, C. M., Dong, H., Webster, W. S., Krejci, K. G., Lobo, J. R., Sengupta, S., Chen, L., Zincke, H., Blute, M.L., Strome, S. E., Leibovich, B. C., Kwon, E. D. (2004). Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. Proc. Natl. Acad. Sci. USA. 101(49):17174-17179.
114. Tirapu, I., Huarte, E., Guiducci, C., Arina, A., Zaratiegui, M., Murillo, O., Gonzalez, A., Berasain, C., Berraondo, P., Fortes, P., Prieto, J., Colombo, M. P., Chen, L., Melero, I. (2006). Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma. Cancer Res. 66(4):2442-2450.
115. Todo, T., Martuza, R. L., Dallman, M. J., Rabkin, S. D. (2001). In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity. Cancer Res. 61(1):153-161.
116. Trentin, L., Perin, A., Siviero, M., Piazza, F., Facco, M., Gurrieri, C., Galvan, S., Adami, F., Agostini, C., Pizzolo, G., Zambello, R., Semenzato, G. (2000). B7 costimulatory molecules from malignant cells in patients with B-cell chronic lymphoproliferative disorders trigger t-cell proliferation. Cancer 89(6):1259-1268.
117. Tringler, B., Zhuo, S., Pilkington, G., Torkko, K. C., Singh, M., Lucia, M. S., Heinz, D. E., Papkoff, J., Shroyer, K. R. (2005). B7-h4 is highly expressed in ductal and lobular breast cancer. Clin. Cancer Res. 11(5):1842-1848.
118. Tseng, S. Y., Otsuji, M., Gorski, K., Huang, X., Slansky, J. E., Pai, S. I., Shalabi, A., Shin, T., Pardoll, D. M., Tsuchiya, H. (2001). B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193(7):839-846.
119. Ullrich, S. E., Pride, M. W., Moodycliffe, A. M. (1998). Antibodies to the costimulatory molecule CD86 interfere with ultraviolet radiation-induced immune suppression. Immunology 94(3):417-423.
120. van Elsas, A., Hurwitz, A. A., Allison, J. P. (1999). Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J. Exp. Med. 190(3):355-366.
121. Wallin, J. J., Liang, L., Bakardjiev, A., Sha, W. C. (2001). Enhancement of CD8+ T cell responses by ICOS/B7h costimulation. J. Immunol. 167(1):132-139.
122. Wang, L., Fraser, C. C., Kikly, K., Wells, A. D., Han, R., Coyle, A. J., Chen, L., Hancock, W. W. (2005). B7-H3 promotes acute and chronic allograft rejection. Eur. J. Immunol. 35(2):428-438.
123. Wang, S., Chen, L. (2004). Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses. Microbes Infect. 6(8):759-766.
124. Wang, S., Bajorath, J., Flies, D. B., Dong, H., Honjo, T., Chen, L. (2003). Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med. 197(9):1083-1091.
125. Wintterle, S., Schreiner, B., Mitsdoerffer, M., Schneider, D., Chen, L., Meyermann, R., Weller, M., Wiendl, H. (2003). Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Res. 63(21):7462-7467.
126. Yamazaki, T., Akiba, H., Koyanagi, A., Azuma, M., Yagita, H., Okumura, K. (2005). Blockade of B7-H1 on Macrophages Suppresses CD4+ T Cell Proliferation by Augmenting IFN-[gamma]-Induced Nitric Oxide Production. J. Immunol. 175(3):1586-1592.
127. Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T., Tsuchiya, H., Pardoll, D. M., Okumura, K., Azuma, M., Yagita, H. (2002). Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169(10):5538-5545.
128. Ye, Z., Hellstrom, I., Hayden-Ledbetter, M., Dahlin, A., Ledbetter, J. A., Hellstrom, K. E. (2002). Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB. Nat. Med. 8(4):343-348.
129. Yoshinaga, S. K., Whoriskey, J. S., Khare, S. D., Sarmiento, U., Guo, J., Horan, T., Shih, G., Zhang, M., Coccia, M. A., Kohno, T., Tafuri-Bladt, A., Brankow, D., Campbell, P., Chang, D., Chiu, L., Dai, T., Duncan, G., Elliott, G. S., Hui, A., McCabe, S. M., Scully, S., Shahinian, A., Shaklee, C. L., Van, G., Mak, T. W., Senaldi, G. (1999). T-cell co-stimulation through B7RP-1 and ICOS. Nature 402(6763):827-832.
130. Youngnak, P., Kozono, Y., Kozono, H., Iwai, H., Otsuki, N., Jin, H., Omura, K., Yagita, H., Pardoll, D. M., Chen, L., Azuma, M. (2003). Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochem. Biophys. Res. Commun. 307(3): 672-677.
131. Zang, X., Loke, P., Kim, J., Murphy, K., Waitz, R., Allison, J. P. (2003). B7x: a widely expressed B7 family member that inhibits T cell activation. Proc. Natl. Acad. Sci. USA 100(18):10388-10392.
132. Zuberek, K., Ling, V., Wu, P., Ma, H. L., Leonard, J. P., Collins, M., Dunussi-Joannopoulos, K. (2003). Comparable in vivo efficacy of CD28/B7, ICOS/GL50, and ICOS/GL50B costimulatory pathways in murine tumor models: IFNgamma-dependent enhancement of CTL priming, effector functions, and tumor specific memory CTL. Cell. Immunol. 225(1):53-63.